Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
32.30
-0.51 (-1.55%)
At close: Dec 5, 2025, 4:00 PM EST
32.94
+0.64 (1.98%)
After-hours: Dec 5, 2025, 6:51 PM EST
Twist Bioscience Stock Forecast
Stock Price Forecast
The 9 analysts that cover Twist Bioscience stock have a consensus rating of "Buy" and an average price target of $46.33, which forecasts a 43.44% increase in the stock price over the next year. The lowest target is $33 and the highest is $62.
Price Target: $46.33 (+43.44%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +14.55% | Nov 17, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $41 | Buy | Initiates | $41 | +26.93% | Nov 4, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $46 → $42 | Buy | Maintains | $46 → $42 | +30.03% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $40 | Buy | Maintains | $45 → $40 | +23.84% | Oct 2, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +48.61% | May 6, 2025 |
Financial Forecast
Revenue This Year
443.95M
from 376.57M
Increased by 17.89%
Revenue Next Year
518.57M
from 443.95M
Increased by 16.81%
EPS This Year
-1.55
from -1.30
EPS Next Year
-1.30
from -1.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 471.5M | 555.5M | |||
| Avg | 444.0M | 518.6M | |||
| Low | 420.0M | 479.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 25.2% | 25.1% | |||
| Avg | 17.9% | 16.8% | |||
| Low | 11.5% | 7.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.05 | -0.82 |
| Avg | -1.55 | -1.30 |
| Low | -2.35 | -2.28 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.